Blood Test Achieves 93% Accuracy for Ovarian Cancer Detection
Multi-biomarker platform combining proteins, lipids, and machine learning outperforms traditional single-marker tests in 950-patient study.
Multi-biomarker platform combining proteins, lipids, and machine learning outperforms traditional single-marker tests in 950-patient study.
The test is approved to identify patients eligible for Hernexeos, an orally administered targeted treatment for HER2 (ERBB2)-mutant non-small cell lung cancer.
A collaborative study has developed a low-cost, open-source, lyophilized RT-LAMP assay for pathogen detection.
Despite powerful advances in precision medicine, most doctors remain untrained in these emerging diagnostic tools.
Read MoreA new study reveals that a simple blood test using single-cell sequencing of rare stem cells can detect early signs of leukemia.
Read MoreNGS-based MRD testing offers unprecedented sensitivity and breadth in detecting low-frequency leukemic clones.
Read MoreA study shows that saliva contains genetic markers linked to systemic diseases for a non-invasive alternative to blood-based diagnostics.
Read MorePrecision oncology is undergoing rapid transformation driven by NGS technology, but systemic barriers in testing access must be overcome.
Read MoreMost Medicaid-enrolled children with autism or intellectual disability are not receiving recommended genetic testing.
Read MoreResearchers have developed a nanopore sensor using 2D materials, marking a breakthrough toward DNA sequencing for precision medicine.
Read MoreRutgers and Yale engineers have developed a portable device that rapidly detects rare genetic mutations from a single drop of blood.
Read MoreResearchers have developed a blood-based Healthspan Proteomic Score (HPS) that predicts biological aging and risk of chronic diseases.
Read MoreResearchers have developed a generative AI tool, TWAVE, that identifies networks of genes responsible for complex diseases.
Read MoreQuidelOrtho is refocusing its molecular diagnostics strategy by discontinuing its Savanna platform and planning to acquire LEX Diagnostics.
Read MoreAMDI has completed a successful clinical study of its Fast PCR-based Mini Respiratory Panel and earned MDSAP certification.
Read MoreSeer, Inc. and Korea University have launched a groundbreaking, large-scale proteomics study using the Proteograph Platform.
Read MoreAMP has released a three-part series defining the essential roles and competencies of clinical bioinformatics in molecular diagnostic labs.
Read MoreNeoGenomics launched its PanTracer Family of genomic profiling tests and Paletrra, an AI-driven spatial proteomics platform.
Read More